Longevity & AgingGLP-1 Weight Loss Drugs Don't Cause Extra Muscle Loss Beyond Normal Dieting
A study published in Cell Reports Medicine examined whether GLP-1 drugs like semaglutide and tirzepatide cause disproportionate muscle loss during weight loss. Earlier large trials suggested up to 40% of weight lost on these drugs came from lean body mass, raising alarms. The new research clarifies that lean body mass includes organs, bones, and water — not just muscle. In obese mice, tirzepatide caused modest absolute muscle reductions, but muscle-to-body-weight ratios actually improved. Liver mass dropped significantly, helping explain the lean body mass numbers. Functional tests showed grip strength and endurance were preserved or improved relative to body weight. The findings suggest GLP-1 drugs are no worse for muscle than ordinary caloric restriction.
